{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T13:21:45Z","timestamp":1696857705119},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,1,14]],"date-time":"2005-01-14T00:00:00Z","timestamp":1105660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s00467-004-1679-6","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T15:35:40Z","timestamp":1105630540000},"page":"389-392","source":"Crossref","is-referenced-by-count":13,"title":["The therapeutic potential of novel phosphate binders"],"prefix":"10.1007","volume":"20","author":[{"given":"Uwe","family":"Querfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,1,14]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607?617","journal-title":"Am J Kidney Dis"},{"key":"CR2","first-page":"318","volume":"54","author":"Block","year":"2000","unstructured":"Block GA (2000) Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin Nephrol 54:318?324","journal-title":"Clin Nephrol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","volume":"35","author":"Block","year":"2000","unstructured":"Block GA, Port FK (2000) Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35:1226?1237","journal-title":"Am J Kidney Dis"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1542\/peds.111.6.1416","volume":"111","author":"Hogg","year":"2003","unstructured":"Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National Kidney Foundation?s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416?1421","journal-title":"Pediatrics"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","volume":"42","author":"Eknoyan","year":"2004","unstructured":"Eknoyan G, Levin A, Levin N (2004) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1?S201","journal-title":"Am J Kidney Dis"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","volume":"56","author":"Rostand","year":"1999","unstructured":"Rostand SG, Drueke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:383?392","journal-title":"Kidney Int"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100?105","journal-title":"Circulation"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/hh2401.101070","volume":"89","author":"Steitz","year":"2001","unstructured":"Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89:1147?1154","journal-title":"Circ Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","volume":"63","author":"Moe","year":"2003","unstructured":"Moe SM, Duan D, Doehle BP, O?Neill KD, Chen NX (2003) Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003?1011","journal-title":"Kidney Int"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0272-6386(97)90352-8","volume":"29","author":"Hsu","year":"1997","unstructured":"Hsu CH (1997) Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 29:641?649","journal-title":"Am J Kidney Dis"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","volume":"73","author":"Portale","year":"1984","unstructured":"Portale AA, Booth BE, Halloran BP, Morris RC Jr (1984) Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73:1580?1589","journal-title":"J Clin Invest"},{"key":"CR12","unstructured":"Kuizon BD, Salusky I (2004) Renal osteodystrophy. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology. Lippincott Williams and Wilkins, Philadelphia, pp 1347?1373"},{"key":"CR13","first-page":"539","volume":"4","author":"Clark","year":"1989","unstructured":"Clark AG, Oner A, Ward G, Turner C, Rigden SP, Haxcock GB, Chantler C (1989) Safety and efficacy of calcium carbonate in children with chronic renal failure. Nephrol Dial Transplant 4:539?544","journal-title":"Nephrol Dial Transplant"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478?1483","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/ndt\/15.11.1892","volume":"15","author":"Eifinger","year":"2000","unstructured":"Eifinger F, Wahn F, Querfeld U, Pollok M, Gevargez A, Kriener P, Gronemeyer D (2000) Coronary artery calcifications in children and young adults treated with renal replacement therapy. Nephrol Dial Transplant 15:1892?1894","journal-title":"Nephrol Dial Transplant"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ndt\/17.1.14","volume":"17","author":"Hergesell","year":"2002","unstructured":"Hergesell O, Ritz E (2002) Phosphate binders in uraemia: pharmacodynamics, pharmacoeconomics, pharmacoethics. Nephrol Dial Transplant 17:14?17","journal-title":"Nephrol Dial Transplant"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1681\/ASN.V1061274","volume":"10","author":"Hsu","year":"1999","unstructured":"Hsu CH, Patel SR, Young EW (1999) New phosphate binding agents: ferric compounds. J Am Soc Nephrol 10:1274?1280","journal-title":"J Am Soc Nephrol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/ndt\/14.4.1045","volume":"14","author":"Chang","year":"1999","unstructured":"Chang JM, Hwang SJ, Tsai JC, Chen HC, Guh JY, Lai YH (1999) Effect of ferric polymaltose complex as a phosphate binder in haemodialysis patients. Nephrol Dial Transplant 14:1045?1047","journal-title":"Nephrol Dial Transplant"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ndt\/14.4.863","volume":"14","author":"Hergesell","year":"1999","unstructured":"Hergesell O, Ritz E (1999) Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients. Nephrol Dial Transplant 14:863?867","journal-title":"Nephrol Dial Transplant"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ndt\/17.2.265","volume":"17","author":"Yang","year":"2002","unstructured":"Yang WC, Yang CS, Hou CC, Wu TH, Young EW, Hsu CH (2002) An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: ferric citrate. Nephrol Dial Transplant 17:265?270","journal-title":"Nephrol Dial Transplant"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-4274(82)90005-4","volume":"14","author":"Basu","year":"1982","unstructured":"Basu A, Chakrabarty K, Chatterjee GC (1982) Neurotoxicity of lanthanum chloride in newborn chicks. Toxicol Lett 14:21?25","journal-title":"Toxicol Lett"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0272-6386(03)00554-7","volume":"42","author":"Joy","year":"2003","unstructured":"Joy MS, Finn WF (2003) Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia. Am J Kidney Dis 42:96?107","journal-title":"Am J Kidney Dis"},{"key":"CR23","unstructured":"D?Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, Popovic M, Dimkovic N, De Broe ME (2003) A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int [Suppl] S73?S78"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/01.ASN.0000025782.24383.0D","volume":"13","author":"Cozzolino","year":"2002","unstructured":"Cozzolino M, Dusso AS, Liapis H, Finch J, Lu Y, Burke SK, Slatopolsky E (2002) The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. J Am Soc Nephrol 13:2299?2308","journal-title":"J Am Soc Nephrol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1523-1755.2003.00284.x","volume":"64","author":"Cozzolino","year":"2003","unstructured":"Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E (2003) Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int 64:1653?1661","journal-title":"Kidney Int"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245?252","journal-title":"Kidney Int"},{"key":"CR27","first-page":"C16","volume":"18","author":"Pieper","year":"2003","unstructured":"Pieper A-K, Haffner D, M\u00fcller-H\u00f6nger R, Hoppe B, Plank C, Offner G, Bonzel K-E, John U, Fr\u00fcnd S, Klaus G, Link A, D\u00fcker G, Querfeld U (2003) Sevelamer vs. calcium acetate in children with chronic renal failure (abstract). Pediatr Nephrol 18:C16","journal-title":"Pediatr Nephrol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","volume":"65","author":"Takahashi","year":"2004","unstructured":"Takahashi Y, Tanaka A, Nakamura T, Fukuwatari T, Shibata K, Shimada N, Ebihara I, Koide H (2004) Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 65:1099?1104","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-004-1679-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1679-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T00:46:38Z","timestamp":1625359598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-004-1679-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,14]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["1679"],"URL":"https:\/\/doi.org\/10.1007\/s00467-004-1679-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,14]]}}}